Chemed's Kevin J McNamara proposes $1.08M share sale
The notice also lists three earlier sales of 2,000 shares each by Kevin J McNamara in August and September 2026.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Filing Summary
Chemed Corporation (CHE) lists a proposed sale for the account of officer/director Kevin J McNamara of 2,000 common shares, with an aggregate market value of $1,084,360 and an approximate sale date of November 3, 2026. Merrill Lynch is listed as broker. The notice also lists prior sales by McNamara of 2,000 shares each on August 21, September 17 and September 28, 2026.
Key Figures
Key Terms
Rule 144 regulatory
Stock Award financial
Stock Exercise financial
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
AI-generated analysis. How Rhea-AI works. Not financial advice.